Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCL001 Cell Injection in Patients With Decompensated Cirrhosis
NCT07488546Phase 2Enrolling by invitation
- Sponsor
- Shanghai Huicun Medical Technology
- Start
- Sep 2025
- Primary completion
- Apr 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hepatocyte in decompensated cirrhosis, sponsored by Shanghai Huicun Medical Technology. Started Sep 2025; status: enrolling by invitation.
02
Drugs
allogeneic hepatocyte
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT07488546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07488546.